RT Journal Article
SR Electronic
T1 An Atomic Approach to the Design and Implementation of a Research Data Warehouse
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.05.21256679
DO 10.1101/2021.05.05.21256679
A1 Visweswaran, Shyam
A1 McLay, Brian
A1 Cappella, Nickie
A1 Morris, Michele
A1 Milnes, John T.
A1 Reis, Steven E.
A1 Silverstein, Jonathan C.
A1 Becich, Michael J.
YR 2021
UL http://medrxiv.org/content/early/2021/05/11/2021.05.05.21256679.abstract
AB Objective As a long-standing Clinical and Translational Science Awards (CTSA) Program hub, the University of Pittsburgh and the University of Pittsburgh Medical Center (UPMC) developed and implemented a modern research data warehouse (RDW) to efficiently provision electronic patient data for clinical and translational research.Methods Because UPMC is one of the largest health care systems in the US with multiple vendors’ electronic health record (EHR) systems, we designed and implemented an RDW named Neptune to serve the specific needs of our CTSA. Neptune uses an atomic design where data is stored at a high level of granularity as represented in source systems. Neptune contains robust patient identity management tailored for research; integrates patient data from multiple sources, including EHRs, health plans, and research studies; and includes knowledge for mapping to standard terminologies. Neptune enables efficient provisioning of data to large analytics-oriented data models and to individual investigators.Results Neptune contains data for more than 5 million patients longitudinally organized as HIPAA Limited Data with dates and includes structured EHR data, clinical documents, health insurance claims, and research data. Neptune is used as a source for patient data for hundreds of IRB-approved research projects by local investigators and for national projects such as the Accrual to Clinical Trials (ACT) network, the All of Us Research Program, and the National Patient-Centered Clinical Research Network.Discussion The design of Neptune was heavily influenced by the large size of UPMC, the varied data sources, and the rich partnership between the University and the healthcare system. It features several desiderata of an RDW, including robust protected health information management, an extensible information storage model, and binding to standard terminologies at the time of data delivery. It also includes several unique aspects, including the physical warehouse straddling the University of Pittsburgh and UPMC networks and management under a HIPAA Business Associates Agreement.Conclusion We describe the design and implementation of an RDW at a large academic health care system that uses a distinctive atomic design where data is stored at a high level of granularity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe research reported in this article was supported by awards from the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH) under award numbers UL1 TR001857, UL1 TR001857-01S1 and U01 TR002623, the Office of the Director of the NIH under award number OT2 OD026554, the National Library of Medicine of the NIH under award number R01 LM012095, and the PCORnet PaTH network RI-CRN-2020-006. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This article describes a patient data warehouse for storing and provisioning patient data that is governed by a HIPAA Business Associates Agreement with the health care system. As such it does not require an IRB protocol.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data in the patient data warehouse described in the article cannot be shared publicly due to the privacy of individuals.